openPR Logo
Press release

Global Absorbable Hemostats Market to grow at a CAGR of 6.47% by 2030, Evaluates DelveInsight | Baxter, Johnson & Johnson, BD, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech

05-07-2024 08:41 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Global Absorbable Hemostats Market to grow at a CAGR of 6.47%

As per DelveInsight's assessment, the Absorbable Hemostats Market is expected to grow at an immense pace in the coming years owing to the The increasing prevalence of pandemic such as COVID-19, Pre- and post-operation and some few of the other applications where Absorbable Hemostats have been used, which is expected to drive the demand for Absorbable Hemostats in the upcoming years.

DelveInsight's "Absorbable Hemostats Global Market Insights, Competitive Landscape, and Market Forecast - 2030" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Absorbable Hemostats companies actively working in the market.

Absorbable Hemostats Overview
Absorbable hemostats are medical devices used to control bleeding during surgical procedures or after traumatic injuries. Unlike traditional hemostatic agents that remain in the body indefinitely, absorbable hemostats are designed to be absorbed by the body over time, eventually breaking down and being metabolized or excreted.

To know more about why North America is leading the market growth in the Absorbable Hemostats market, get a snapshot of the report Absorbable Hemostats Market Trends
https://www.delveinsight.com/report-store/absorbable-hemostats-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Absorbable Hemostats Market Insights
Geographically, North America is projected to hold the greatest portion in the Global Absorbable Hemostats market. Additionally, the increasing incidence of spine-related disorders and other conditions is anticipated to further boost the absorbable hemostats market in the United States.

DelveInsight Analysis: The Global Advanced Wound Care market size is anticipated to grow with a CAGR of 6.47% during the forecasted period (2024-2030).

Recent Developments in the Absorbable Hemostats Market Report
• On March 25, 2020, Ethicon, part of the Johnson & Johnson Medical Devices Companies, announced the strategic regional launch of SURGICEL® POWDER ABSORBABLE HEMOSTAT in Australia, New Zealand, and Thailand.
• Thus, owing to such developments in the market, rapid growth will be observed in the Absorbable Hemostats market during the forecast period

To read more about the latest highlights related to Absorbable Hemostats, get a snapshot of the key highlights entailed in the Absorbable Hemostats
https://www.delveinsight.com/sample-request/absorbable-hemostats-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Key Players in the Absorbable Hemostats Market
Some of the key market players operating in the Absorbable Hemostats market include - B.Braun, Baxter, Johnson & Johnson, BD, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech, Guizhou Jin Jiu Biotech, Beijing Taikesiman, Foryou Medical, Saikesaisi Holdings Group, Biotemed, Hangzhou Singclean Medical Products, Teleflex Incorporated, Hemostasis, LLC, Stryker, Samyang Holdings Corporation, and others.

COVID-19 Impact Analysis on the Absorbable Hemostats Market
The absorbable hemostats market is experiencing an increase in product demand due to several factors, with one significant driver being the growing prevalence of spinal disorders.
Additionally, The absorbable hemostats market experienced significant disruption due to the unprecedented COVID-19 outbreak. Lockdown measures implemented during the pandemic resulted in reduced patient visits and the temporary suspension of non-essential surgical procedures, as priority was given to treating COVID-19 patients. However, with the introduction of vaccines and the subsequent easing of restrictions, normal operations have resumed, driving growth in the absorbable hemostats market during the post-pandemic period, among other things, are some of the factors that could increase the global Absorbable Hemostats market during the forecast period (2024-2030).

Scope of the Absorbable Hemostats Market Report
• Coverage: Global
• Study Period: 2021-2030
• Absorbable Hemostats Market Segmentation By Type: Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Others
• Absorbable Hemostats Market Segmentation By Formulants: Matrix & Gel Hemostats, Sponge Hemostats, Powder Hemostats, Others
• Absorbable Hemostats Market Segmentation By Application: Neurosurgery, Orthopedic Surgery, General Surgery, Reconstructive Surgery, Others
• Absorbable Hemostats Market Segmentation By End-User: By End-User (Hospitals, Ambulatory Surgical Centers, Laboratories, And Others
• Absorbable Hemostats Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Absorbable Hemostats Companies: B.Braun, Baxter, Johnson & Johnson, BD, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech, Guizhou Jin Jiu Biotech, Beijing Taikesiman, Foryou Medical, Saikesaisi Holdings Group, Biotemed, Hangzhou Singclean Medical Products, Teleflex Incorporated, Hemostasis, LLC, Stryker, Samyang Holdings Corporation, among others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Which MedTech key players in the Absorbable Hemostats market are set to emerge as the trendsetter explore @ Absorbable Hemostats
https://www.delveinsight.com/sample-request/absorbable-hemostats-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1 Absorbable Hemostats Market Report Introduction
2 Absorbable Hemostats Market Executive summary
3 Regulatory and Patent Analysis
4 Absorbable Hemostats Market Key Factors Analysis
5 Porter's Five Forces Analysis
6 COVID-19 Impact Analysis on Absorbable Hemostats Market
7 Absorbable Hemostats Market Layout
8 Global Company Share Analysis - Key 3-5 Companies
9 Company and Product Profiles
10 Project Approach
11. About DelveInsight

Interested in knowing how the Absorbable Hemostats market will grow by 2030? Click to get a snapshot of the Absorbable Hemostats Market Analysis
https://www.delveinsight.com/sample-request/absorbable-hemostats-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Related Reports
Systemic Sclerosis Market
https://www.delveinsight.com/report-store/systemic-sclerosis-market
DelveInsight's "Systemic Sclerosis Market Insights, Epidemiology, and Market Forecast - 2032" comprehensively analyzes Systemic Sclerosis. The report includes a detailed examination of the historical and projected epidemiology data that includes diagnosed prevalent cases of Systemic Sclerosis segmented by gender-specific, age-specific, and type-specific cases.

Ventilator Market
https://www.delveinsight.com/report-store/ventilators-market
Ventilators Market By Mobility (Intensive Care Ventilators, Portable/Transportable Ventilators), By Type (Adult/Pediatric Ventilators, Neonatal/Infant Ventilators), By Interface (Invasive Ventilation, Non-Invasive Ventilation), By End-User (Hospitals, Home Care, Ambulatory Surgical Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2028 owing to launch of advanced devices and increasing prevalence of respiratory diseases such as COPD.

Vascular Graft Devices Market
https://www.delveinsight.com/report-store/vascular-grafts-market
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2028 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.

Bladder Scanners Market
https://www.delveinsight.com/report-store/bladder-scanners-market
"DelveInsight's 'Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2030' report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Iga Nephropathy Market
https://www.delveinsight.com/report-store/iga-nephropathy-market
DelveInsight's "IgA Nephropathy Market Insights, Epidemiology and Market Forecast - 2032" report delivers an in-depth understanding of the IgA Nephropathy, historical and forecasted epidemiology as well as the IgA Nephropathy market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, Japan, and China.

Vutrisiran Market
https://www.delveinsight.com/report-store/vutrisiran-market
DelveInsight's "Vutrisiran Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Vutrisiran, historical and forecasted epidemiology as well as the Vutrisiran market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Gastroesophageal Reflux Disease Market
https://www.delveinsight.com/report-store/gastroesophageal-reflux-disease-gerd-market
DelveInsight's "Gastroesophageal Reflux Disease (GERD) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Gastroesophageal Reflux Disease (GERD), historical and forecasted epidemiology as well as the Gastroesophageal Reflux Disease (GERD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
https://www.delveinsight.com/medical-devices

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Absorbable Hemostats Market to grow at a CAGR of 6.47% by 2030, Evaluates DelveInsight | Baxter, Johnson & Johnson, BD, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech here

News-ID: 3487826 • Views:

More Releases from DelveInsight Business Research

Heart Failure Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Abbott, Berlin Heart GmbH, Biotronik, Boston Scientific Corp, Jarvik Heart Inc., Lepu Medical
Heart Failure Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Thera …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Heart Failure pipeline constitutes 75+ key companies continuously working towards developing 90+ Heart Failure treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Heart Failure Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Heart Failure Market. The Heart
Primary Hyperoxaluria Pipeline and Clinical Trials Assessment: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Alnylam Pharmaceuticals, Inc., Genentech, Inc., Dicerna Pharmaceuticals, Inc., Pfizer Inc., Zhejiang Tianxin Pharmaceutica
Primary Hyperoxaluria Pipeline and Clinical Trials Assessment: FDA Approvals, Th …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Primary Hyperoxaluria pipeline constitutes 8+ key companies continuously working towards developing 8+ Primary Hyperoxaluria treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Primary Hyperoxaluria Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Primary Hyperoxaluria Market. The Primary
Pulmonary Arterial Hypertension Pipeline and Clinical Trials Assessment, 2024 Updates: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Ribomic, Gmax Biopharm LLC., Novartis, Cereno Scientific AB, Insmed Incorporated, Aerovate Therape
Pulmonary Arterial Hypertension Pipeline and Clinical Trials Assessment, 2024 Up …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Pulmonary Arterial Hypertension pipeline constitutes 55+ key companies continuously working towards developing 55+ Pulmonary Arterial Hypertension treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Pulmonary Arterial Hypertension Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Pulmonary Arterial
Endometrial Cancer Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)
Endometrial Cancer Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discove …
DelveInsight's, "Endometrial Cancer Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Endometrial Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Endometrial Cancer Pipeline Report • DelveInsight's Endometrial Cancer pipeline

All 5 Releases


More Releases for Hemostats

Global Hemostats & Sealants Market Growth 2019-2024
Market Research Report Store offers a latest published report on Hemostats & Sealants Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Hemostats & Sealants players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.To analyze the Hemostats & Sealants with
Global Hemostats and Tissue Sealants Market
Global Hemostats and Tissue Sealants Market –Industry Analysis and Forecast 2018-2026 – By Product Type, Application, End-user, and Region. Global Hemostats and Tissue Sealants Market was valued US$ 2.78 Bn in 2017 and is expected to reach US$ 5.29 Bn by 2026, at a CAGR of 8.37% during a forecast period. Increasing incidence of chronic diseases, the wide range of applications, patient safety & quick recovery, number of surgeries and growing aging
Hemostats Market worth $3.03 billion by 2023
According to the new market research “"Hemostats Market by Product (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), Application (Gynecology, Neurology, Cardiovascular, Reconstructive), Formulation (Powder, Matrix & Gel, Sheets & Pads) - Global Forecast to 2023", The hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.27 billion in 2018, at a CAGR of 6.0%. Don’t miss out on business opportunities in Hemostats Market . Speak to our
Hemostats Market: Challenges and Opportunities Report 2019
Hemostat is a surgical tool used to control bleeding during surgery. Hemostats are applied by the means of tissue sealants and tissue adhesion agents. Tissue sealants and adhesives are mainly classified into two types namely, physical agents and biological substrates. Tissue sealants, tissue adhesives and adhesion prevention products are rapidly replacing conventional sutures for wound and incision closure. Advantages of tissue sealants, tissue adhesives and adhesion prevention products over conventional
Hemostats - Medical Devices Pipeline Assessment, 2016
Publisher's Medical Devices sector report, "Hemostats - Medical Devices Pipeline Assessment, 2016" provides an overview of Hemostats currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end
Hemostats - Medical Devices Pipeline Assessment, 2016
Summary Publisher's Medical Devices sector report, "Hemostats - Medical Devices Pipeline Assessment, 2016" provides an overview of Hemostats currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end